New 'Master Switch' Linked to Aggressive Breast Cancer, with Drug Shown to Slow Tumor Growth

New 'master switch' linked to aggressive breast cancer, with drug shown to slow tumor growth

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have identified a 'master switch' responsible for driving tumor growth in an aggressive form of breast cancer. Blocking the switch with a targeted drug was also found to reduce cancer cell growth and spread.

New master switch linked to aggressive breast cancer; drug slows tumour

Researchers at the Yong Loo Lin School of Medicine at the National University of Singapore have identified a molecular “master switch” that appears to coordinate tumour growth, cancer stem-cell maintenance and treatment resistance in triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease. The regulator, known as DP103, was found […]